Biosimilar Education Strategies for Physicians And Clinicians

There are many critical stakeholders in the biosimilar industry, but arguably physicians are one of the most important. This eBook is a collection of articles written from January 2019 to July 2019 that homes in on the role of the physician in bolstering biosimilar markets all over the world. Whether it be educating their patients, colleagues, or health systems, physicians can be a leading factor encouraging patient acceptance and uptake of biosimilars. In this collection of articles, we unpack strategies for better engaging and educating this important stakeholder base, while also sharing physicians’ current thought processes on how biosimilars can contribute to value-based healthcare globally.